Roche launches COVID-19 variant test to help monitor mutations

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche

ZURICH (Reuters) - Roche is launching a SARS-CoV-2 variant test to help monitor emerging coronavirus mutations, the Swiss pharmaceuticals group said on Tuesday. The test runs on widely used high-throughput systems and is for research purposes only.

"Periodic assessments against emerging variants have shown that Roche’s current diagnostic tests for detecting active SARS-CoV-2 infections remain accurate and effective," it said.

(Reporting by Michael Shields; Editing by Riham Alkousaa)